Single-cell mapping of alternative splicing linked to checkpoint immunotherapy response.

Fuente: PubMed
Saved in:
Bibliographic Details
Main Authors: Xiong, Jieyi, Bricard, Orian, Arijs, Ingrid, Demeulemeester, Jonas, Gu, Chen, Thienpont, Bernard, Daaboul, Danie, Bassez, Ayse, Bechter, Oliver, Poźniak, Joanna, Vos, Hanne, Nevelsteen, Ines, Torfs, Sofie, Santos, Sara Aibar, Lan, Qing, Hou, Yong, Van Oudenhove, Lore, Boons, Gitta, Qian, Junbin, Aerts, Stein, Smeets, Ann, Marine, Jean-Christophe, Lambrechts, Diether
Format: Artículo científico
Language:en
Published: Nucleic acids research 2025
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868266122568007680
author Xiong, Jieyi
Bricard, Orian
Arijs, Ingrid
Demeulemeester, Jonas
Gu, Chen
Thienpont, Bernard
Daaboul, Danie
Bassez, Ayse
Bechter, Oliver
Poźniak, Joanna
Vos, Hanne
Nevelsteen, Ines
Torfs, Sofie
Santos, Sara Aibar
Lan, Qing
Hou, Yong
Van Oudenhove, Lore
Boons, Gitta
Qian, Junbin
Aerts, Stein
Smeets, Ann
Marine, Jean-Christophe
Lambrechts, Diether
author_facet Xiong, Jieyi
Bricard, Orian
Arijs, Ingrid
Demeulemeester, Jonas
Gu, Chen
Thienpont, Bernard
Daaboul, Danie
Bassez, Ayse
Bechter, Oliver
Poźniak, Joanna
Vos, Hanne
Nevelsteen, Ines
Torfs, Sofie
Santos, Sara Aibar
Lan, Qing
Hou, Yong
Van Oudenhove, Lore
Boons, Gitta
Qian, Junbin
Aerts, Stein
Smeets, Ann
Marine, Jean-Christophe
Lambrechts, Diether
Xiong, Jieyi
Bricard, Orian
Arijs, Ingrid
Demeulemeester, Jonas
Gu, Chen
Thienpont, Bernard
Daaboul, Danie
Bassez, Ayse
Bechter, Oliver
Poźniak, Joanna
Vos, Hanne
Nevelsteen, Ines
Torfs, Sofie
Santos, Sara Aibar
Lan, Qing
Hou, Yong
Van Oudenhove, Lore
Boons, Gitta
Qian, Junbin
Aerts, Stein
Smeets, Ann
Marine, Jean-Christophe
Lambrechts, Diether
collection PubMed - marine biology
contents Single-cell mapping of alternative splicing linked to checkpoint immunotherapy response. Xiong, Jieyi Bricard, Orian Arijs, Ingrid Demeulemeester, Jonas Gu, Chen Thienpont, Bernard Daaboul, Danie Bassez, Ayse Bechter, Oliver Poźniak, Joanna Vos, Hanne Nevelsteen, Ines Torfs, Sofie Santos, Sara Aibar Lan, Qing Hou, Yong Van Oudenhove, Lore Boons, Gitta Qian, Junbin Aerts, Stein Smeets, Ann Marine, Jean-Christophe Lambrechts, Diether Humans Single-Cell Analysis Alternative Splicing RNA-Binding Proteins Immunotherapy Tumor Microenvironment Female Immune Checkpoint Inhibitors Antigens, Neoplasm Gene Expression Regulation, Neoplastic Breast Neoplasms Cell Line, Tumor Triple Negative Breast Neoplasms Evidence suggests that alternative RNA splicing (AS) plays a critical role in tumor biology and may contribute to the generation of tumor antigens. Here, we develop a method to detect AS in short-read single-cell 5'-RNA-sequencing data, allowing us to uniquely characterize the heterogeneity and dynamic changes in AS in individual cell types within the tumor microenvironment. We identify numerous splicing events specific to either cancer cells or stromal cell types or for triple-negative versus estrogen receptor-positive breast cancers (BCs). By correlating these splice events with expression of splicing regulators in individual cells, we also identify their potential mediators. For instance, we identify and functionally validate the Epithelial Splicing Regulatory Protein-1 (ESRP1) to drive AS in BCs responding to immune checkpoint blockade (ICB). Prioritization of splicing events based on their likelihood to represent tumor antigens reveals that their aggregated load also correlates with high immune activity in multiple cancers, while also predicting expansion of T cells in BCs receiving ICB and prolonging long-term survival of cancer patients treated with ICB. Collectively, our method provides a framework for analyzing AS in single-cell data and defines a key role for AS in the response to ICB.
format Artículo científico
id pubmed_41273175
institution PubMed
language en
publishDate 2025
publisher Nucleic acids research
record_format pubmed
spellingShingle Single-cell mapping of alternative splicing linked to checkpoint immunotherapy response.
Xiong, Jieyi
Bricard, Orian
Arijs, Ingrid
Demeulemeester, Jonas
Gu, Chen
Thienpont, Bernard
Daaboul, Danie
Bassez, Ayse
Bechter, Oliver
Poźniak, Joanna
Vos, Hanne
Nevelsteen, Ines
Torfs, Sofie
Santos, Sara Aibar
Lan, Qing
Hou, Yong
Van Oudenhove, Lore
Boons, Gitta
Qian, Junbin
Aerts, Stein
Smeets, Ann
Marine, Jean-Christophe
Lambrechts, Diether
Humans
Single-Cell Analysis
Alternative Splicing
RNA-Binding Proteins
Immunotherapy
Tumor Microenvironment
Female
Immune Checkpoint Inhibitors
Antigens, Neoplasm
Gene Expression Regulation, Neoplastic
Breast Neoplasms
Cell Line, Tumor
Triple Negative Breast Neoplasms
Single-cell mapping of alternative splicing linked to checkpoint immunotherapy response. Xiong, Jieyi Bricard, Orian Arijs, Ingrid Demeulemeester, Jonas Gu, Chen Thienpont, Bernard Daaboul, Danie Bassez, Ayse Bechter, Oliver Poźniak, Joanna Vos, Hanne Nevelsteen, Ines Torfs, Sofie Santos, Sara Aibar Lan, Qing Hou, Yong Van Oudenhove, Lore Boons, Gitta Qian, Junbin Aerts, Stein Smeets, Ann Marine, Jean-Christophe Lambrechts, Diether Humans Single-Cell Analysis Alternative Splicing RNA-Binding Proteins Immunotherapy Tumor Microenvironment Female Immune Checkpoint Inhibitors Antigens, Neoplasm Gene Expression Regulation, Neoplastic Breast Neoplasms Cell Line, Tumor Triple Negative Breast Neoplasms Evidence suggests that alternative RNA splicing (AS) plays a critical role in tumor biology and may contribute to the generation of tumor antigens. Here, we develop a method to detect AS in short-read single-cell 5'-RNA-sequencing data, allowing us to uniquely characterize the heterogeneity and dynamic changes in AS in individual cell types within the tumor microenvironment. We identify numerous splicing events specific to either cancer cells or stromal cell types or for triple-negative versus estrogen receptor-positive breast cancers (BCs). By correlating these splice events with expression of splicing regulators in individual cells, we also identify their potential mediators. For instance, we identify and functionally validate the Epithelial Splicing Regulatory Protein-1 (ESRP1) to drive AS in BCs responding to immune checkpoint blockade (ICB). Prioritization of splicing events based on their likelihood to represent tumor antigens reveals that their aggregated load also correlates with high immune activity in multiple cancers, while also predicting expansion of T cells in BCs receiving ICB and prolonging long-term survival of cancer patients treated with ICB. Collectively, our method provides a framework for analyzing AS in single-cell data and defines a key role for AS in the response to ICB.
title Single-cell mapping of alternative splicing linked to checkpoint immunotherapy response.
topic Humans
Single-Cell Analysis
Alternative Splicing
RNA-Binding Proteins
Immunotherapy
Tumor Microenvironment
Female
Immune Checkpoint Inhibitors
Antigens, Neoplasm
Gene Expression Regulation, Neoplastic
Breast Neoplasms
Cell Line, Tumor
Triple Negative Breast Neoplasms
url https://pubmed.ncbi.nlm.nih.gov/41273175/